Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 15 Papillomavirus Infections 9 Uterine Cervical Neoplasms 7 Pancreatic Neoplasms 6 Breast Neoplasms 6 Ovarian Neoplasms 5 Prostatic Neoplasms 4 Neuroendocrine Tumors 4 Neoplasm Metastasis 4 Myasthenia Gravis 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Lung Neoplasms 3 Autoimmune Diseases 3 Thyroid Diseases 2 Pancreatic Cyst 2 Neuroblastoma 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 COVID-19 2 Brain Neoplasms 2 Abortion, Spontaneous 2

Interventions

Etoposide 155 Carboplatin 144 Cisplatin 105 Topotecan 76 durvalumab 52 atezolizumab 50 Irinotecan 45 pembrolizumab 38 Paclitaxel 34 Nivolumab 33 Radiotherapy 31 PM 01183 24 Drug Therapy 24 anlotinib 23 Gemcitabine 21 apatinib 19 Ipilimumab 18 Docetaxel 17 Temozolomide 16 Platinum 16 Radiosurgery 15 Pemetrexed 14 toripalimab 13 tislelizumab 13 olaparib 13 Magnetic Resonance Spectroscopy 13 Bevacizumab 13 rovalpituzumab tesirine 11 amrubicin 11 Specimen Handling 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Data Collection × Clear all

NCT02622581 2025-02-18

CRISP

AIO-Studien-gGmbH

12,400 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡